Phase I/II Trial of Stereotactic Body Radiotherapy With Concurrent Fixed Dose Tyrosine Kinase Inhibitors in Metastatic Renal Cell Carcinoma: Dose Limiting Toxicity and Abscopal Effect.
Clinical trial NCT02334709 · COMPLETED
Trial details
- NCT number
- NCT02334709
- Sponsor
- University Hospital, Ghent
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2016-08-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.